Research Use Only - Not for human consumption. 18+ only.

Selank vs Semax

Evidence-based comparison · Updated 2026

Summary

Selank is better suited for anxiety reduction, mood stabilization, and immune modulation, while Semax is more targeted toward cognitive enhancement, neuroplasticity, and stress resilience under cognitive load. Choose Selank if anxiety is the primary concern and Semax if the goal is improving memory, attention, and mental performance. Both carry a Grade B evidence rating and are compoundable peptides.

Side-by-Side Comparison

SelankSemax
EvidenceBGrade BSmaller human trials, observational studies, or approved in 30+ countriesBGrade BSmaller human trials, observational studies, or approved in 30+ countries
RegulatoryCompoundableCompoundableLegal to compound in the US; approved in other jurisdictions or has historical approvalCompoundableCompoundableLegal to compound in the US; approved in other jurisdictions or has historical approval
Benefits
  • +Reduces anxiety and stress responses
  • +Enhances memory and cognitive function
  • +Improves mood and emotional resilience
  • +Supports immune system modulation
  • +Increases mental clarity and focus
  • +Enhances memory and cognitive function
  • +Increases stress resilience and anxiety reduction
  • +Supports neuroprotection and brain health
  • +Improves attention and mental clarity
  • +Promotes neuroplasticity and learning capacity
Dosage250-500 mcg — 1-2x daily250-500 mcg — 1-2x daily
RouteSubcutaneousSubcutaneous
CategoryCognitive EnhancementCognitive Enhancement

Which Should You Choose?

Selank primarily modulates GABA and dopamine pathways with a strong anxiolytic and immunomodulatory profile, while Semax acts on the HPA axis and endorphin receptor signaling to drive neuroplasticity and cognitive enhancement. Their mechanisms overlap in neuroprotection and fatigue reduction but diverge significantly in their primary targets.

Choose Selank when:

  • +Primary goal is reducing anxiety or stress-driven emotional dysregulation rather than cognitive output
  • +Immune system modulation is a relevant therapeutic target alongside neurological support
  • +Mood stability and emotional resilience are prioritized over raw cognitive performance metrics

Choose Semax when:

  • +Primary goal is improving memory consolidation, learning capacity, or attention under cognitive demand
  • +Neuroplasticity and long-term brain health are the central research objectives
  • +Stress resilience is needed specifically in high-cognitive-load contexts rather than general anxiety management

Stacking Selank and Semax is reported in research-adjacent communities due to their complementary mechanisms, with Selank addressing anxiety and immune tone while Semax drives cognitive enhancement, though controlled clinical data on combined use remains limited.

Frequently Asked Questions

Do Selank and Semax work faster than each other for noticeable effects?
Both peptides are typically administered intranasally, which allows relatively rapid CNS access, but their onset profiles differ by target. Selank's anxiolytic effects are often reported within the first few administrations, sometimes acutely. Semax's cognitive and neuroplasticity benefits are generally described as more cumulative, building over days to weeks of consistent use. Neither has robust head-to-head pharmacokinetic data in human trials.
Can Selank and Semax be stacked together, and is there a rationale for doing so?
The two peptides operate through distinct primary pathways, Selank via GABA and dopamine modulation and Semax via ACTH and endorphin receptor signaling, which provides a mechanistic basis for complementary use. Combining them is anecdotally reported to address both anxiety and cognitive performance simultaneously. However, no controlled clinical trials have evaluated their combined safety or efficacy profile, so any stacking protocol falls outside validated research parameters.
Which peptide is more appropriate if both anxiety and cognitive decline are present?
When both anxiety and cognitive impairment are concurrent concerns, Selank's anxiolytic and neuroprotective properties may address the anxiety component while providing some cognitive support, but Semax's stronger neuroplasticity and memory consolidation profile may be necessary to meaningfully target cognitive decline. Some researchers hypothesize sequential or combined use in this context. Clinical guidance from a qualified provider familiar with peptide research protocols is necessary before drawing practical conclusions.
Are the side effect profiles of Selank and Semax meaningfully different?
Both peptides are generally characterized in the literature as well-tolerated with low adverse effect rates at research doses. Selank's GABAergic activity raises theoretical considerations around sedation or mood flattening at higher doses, while Semax's HPA axis modulation has been noted in some reports to cause transient stimulatory effects or mild irritability. Neither peptide has an extensive long-term human safety dataset, and comparing their risk profiles definitively is not yet supported by the available clinical literature.

Goal-Based Guides

Broader evidence guides for the goals this comparison relates to.

Not sure which fits your research goals?

Use the Goal Finder

Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.

Find My Peptide →